Clinical Trial Update: A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 clinical trial update reports on the safety and tolerability of LY03020 in Chinese healthy subjects and indicates the study has completed. The spon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease Psychosis
• Schizophrenia

Drugs mentioned

• LY03020

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Status: COMPLETED